Biotech backing for new FDA Commissioner

Scott Gottlieb has been confirmed as the new Commissioner of the US Food and Drug Administration (FDA).

It might not have received as much coverage as the simultaneous news regarding the head of another major US federal agency, but Dr Gottlieb’s early actions in the role will be closely watched by pharma and biotech as they await potential changes affecting drug development and the regulatory framework, as well as the FDA itself.

"During his time as a deputy commissioner, Dr Gottlieb was a strong advocate for policies that supported an efficient and streamlined drug development and approval process"